1-3 of 3
Alix Arnaud
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Caplacizumab in Immune-Mediated Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Literature Review and Meta-Analyses of Clinical Trials and Observational Studies

Paul Coppo, Marie Scully, Agathe Nevière, Pauline Le Nouveau, Prerna Patel, Alaeddine Sidhom, Srushhti Trivedi, Rachel Chu, Da Eun Ahn, Gabriela Marcheva, Divyesh Thakker, Gaye Siliman, Alix Arnaud
Journal: Blood
Blood (2024) 144 (Supplement 1): 4001.
https://doi.org/10.1182/blood-2024-204743
Published: 2024
Journal Articles

Cost Comparison of Efanesoctocog Alfa with Existing Factor VIII Replacement Therapies for Major Surgeries in People with Severe Hemophilia a

Janice Staber, Alix Arnaud, Ion Agirrezabal, Lane Anson, Andrew Wilson, Nana Kragh, Doris V. Quon, Allison P Wheeler
Journal: Blood
Blood (2024) 144 (Supplement 1): 2582.
https://doi.org/10.1182/blood-2024-207568
Published: 2024
Journal Articles

Cost-Effectiveness of Caplacizumab in the Warranty Program in Immune Thrombotic Thrombocytopenic Purpura in the USA

Sean D Sullivan, Shruti Chaturvedi, Preety Gautam, Alix Arnaud
Journal: Blood
Blood (2023) 142 (Supplement 1): 5056.
https://doi.org/10.1182/blood-2023-180426
Published: 2023